Larvol Delta - ViralClear-to-Host-Conference-Call-on-September-22-2020-to-Discuss-Phase-2-Human-Trial-of-AntiViral-Merimepodib-Oral-Solution-for-Treatment-of-COVID19

Vicromax (merimepodib) - BioSig Tech

remdesivir - Generic mfg.

https://www.globenewswire.com/news-release/2020/09/09/2091182/0/en/ViralClear-to-Host-Conference-Call-on-September-22-2020-to-Discuss-Phase-2-Human-Trial-of-AntiViral-Merimepodib-Oral-Solution-for-Treatment-of-COVID-19.html

Sep 9, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next